Vertex Pharmaceuticals reported $513.26M in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 175.38M 3.05M
Agios Pharmaceuticals AGIO:US $ 0.41M 0.59M
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Amgen AMGN:US $ 37579M 4797M
Arrowhead Research ARWR:US $ 0M 0M
Biogen BIIB:US $ 7271.1M 1.9M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 44742M 416M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Insmed INSM:US $ 572.61M 8.59M
Intercept Pharmaceuticals ICPT:US $ 530.4M 45.42M
IONIS PHARMACEUT IONS:US $ 1303M 7.54M
Moderna Inc MRNA:US 456M 31M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Novartis NOVN:VX SF 34243M 1526M
Ptc Therapeutics PTCT:US $ 1176.77M 14.94M
Puma Biotechnology PBYI:US $ 96.8M 3.33M
Regeneron Pharmaceuticals REGN:US $ 2698.6M 1M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M
YTE INCY:US $ 33.78M 0.47M